Enzyme-Based Drug Delivery Systems
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 10775
Interests: nanozyme; ferritin; drug delivery; tumor theranostics; cardiovascular disease
Special Issues, Collections and Topics in MDPI journals
Interests: nanozyme; cancer theranostics; sonodynamic therapy; antibacterial treatment
Interests: nanozyme; theranostics; urinary tumor; selenium nanoparticles; sonodynamic therapy
Enzyme-based drug delivery systems usually refer to a specific drug delivery strategy, which can be catalytically activated at the lesion to achieve more efficient on-demand drug delivery. With the rapid development of precise drug delivery systems contributed by doctors, pharmacists, and scientists from biology, physics, chemistry, material, electrical engineering, mechanical engineering, etc., many efforts have been made in the design and construction, therapeutic efficacy, and detailed therapeutic mechanism of this promising field to promote the clinical translation of enzyme-based drug delivery systems.
In the Special Issue, the articles, reviews, and perspectives are included but are not limited to the following two topics:
- Artificial-enzyme-based (including but not limited to nanozyme) drug delivery systems;
- Natural-enzyme-based drug delivery systems.
Prof. Dr. Kelong Fan
Prof. Dr. Xianwen Wang
Prof. Dr. Hong-Xing Liu
Prof. Dr. Xiaojun Cai
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery
- natural enzyme